We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Skin Test Developed For Tuberculosis Infection

By LabMedica International staff writers
Posted on 02 Jun 2016
Print article
Image: A strongly positive Mantoux tuberculin skin test (Photo courtesy of Mudnsky).
Image: A strongly positive Mantoux tuberculin skin test (Photo courtesy of Mudnsky).
A new skin test for tuberculosis infection has been tested and has proven safe, easy to administer and accurate in two Phase III clinical trials. The test is administered like a tuberculin skin test (TST), and results are interpreted by measuring the size of the skin induration two or three days later.

The test, known as C-Tb, combines the field friendliness of the purified protein derivative PPD-based tuberculin skin test with the high specificity of interferon gamma release assays, or IGRAs. Introduced a decade ago, IGRAs have high specificity, producing few false positives, but require blood samples and complicated laboratory work, which has limited their widespread use.

Scientists at the Statens Serum Institut (Copenhagen, Denmark) colleagues conducted a double-blinded study of C-Tb, which measures the body's immune response to two TB antigens, EAST-6 and CFP10, in 979 participants enrolled at 13 clinical trial sites in Spain. Participants, all adults, ranged in TB status from presumed uninfected through intermediate and high risk of latent TB to active disease. The investigators found that both C-Tb and the IGRA had a specificity of 97 %; C-Tb was highly concordant to IGRA in 95% of study participants; and the specificity of C-Tb, unlike the TST, was not impacted by the BCG vaccine, the partially effective vaccine that many residents in the developing world receive. TST specificity in this group was only 62%.

In the second double-blinded trial, the scientists were primarily concerned with testing how accurate C-Tb was in HIV-positive patients and in young children, populations in which the accuracy of the TST and the IGRA is known to be compromised. The study, conducted in South Africa, enrolled 1,090 participants, including 299 patients with human immunodeficiency virus (HIV) and 402 children as young as 28 days. Among participants with HIV, the ability of all three tests to detect TB infection was diminished, though the C-Tb appeared more robust in HIV-infected participants with low CD4 T cell counts and among children under 5, C-Tb was comparable with the other two tests in identifying those infected.

Morten Ruhwald, MD, PhD, head of human immunology at Statens Serum Institut, said, “Another advantage of C-Tb is that the measurement of infection, a 5 mm or larger induration, is universal across patients with different risk factors, including HIV infection. With TST, the size of the induration is often adjusted to increase its accuracy in measuring infection in different patient populations.” The study was presented at the American Thoracic Society (ATS) international conference held May 19-24, 2016, in Washington, DC, USA.

Related Links:
Statens Serum Institut

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.